Physician Directory

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Larissa A. Korde, MD, MPH

Dr. Korde is an assistant professor in the UW Division of Medical Oncology and specializes in the care of breast cancer patients.

Patient Care Philosophy:

The past decade has seen major advances in the screening, prevention, and treatment of breast cancer. I believe the role of a physician is to help patients understand this increasingly complex information, to make recommendations based on the most current scientific data, and to provide patients with all the information necessary to make treatment decisions that are best for them.  I also support participation in well-designed clinical trials that will help us further understand breast cancer, and will lead to continued progress in optimizing treatment for individual patients.

Dr. Korde's Resume


Title

  • Assistant Professor, Division of Medical Oncology,University of Washington School of Medicine
  • Assistant Member, Public Health Sciences Division, Fred Hutchinson Cancer Research Center
  • Director, Prevention Center Shared Resource, Fred Hutchinson Cancer Research Center

Clinical Expertise

Breast cancer treatment, breast cancer risk assessment, genetics, and prevention

Experience

Staff Clinician - Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, December 2005 – May 2009

Attending Physician – NCI/Navy Medical Oncology Service, National Naval Medical Center, Bethesda MD, August 2006 – May 2009 

Education And Training

  • Cancer Prevention Fellow, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD
    July 2002 – December 2005
  • Medical Oncology Fellow,  Medical Oncology Clinical Research Unit, Center for Cancer Research National Cancer Institute, National Institutes of Health, Bethesda, MD July 2001 – June 2004
  • Internal Medicine Resident and Intern, Georgetown University Medical Center, Washington, DC July 1998 – June 2001
  • George Washington University, School of Public Health and Health Services, Washington, DC
  • Master of Public Health, New York Medical College,  Valhalla, NY, September 2003
  • Doctor of Medicine, New York Medical College,  Valhalla, NY, May 1998

More Information

For more information about Dr. Larissa A. Korde's clinical and research expertise, click here.
 

Clinical Trials

Dr. Korde is the SCCA lead investigator for the following clinical trials:

Dr. Korde's Story


Dr. Korde is an assistant professor in the Division of Medical Oncology and specializes in the care of breast cancer patients.  She received a B.A. from the College of William and Mary in 1992, an M.D. from New York Medical College in 1998, and a Masters degree in public health from the George Washington University in 2003.  Dr. Korde completed her residency in Internal Medicine at Georgetown University Medical Center, and completed her Medical Oncology fellowship and a Cancer Prevention fellowship at the NCI, and then joined the Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, NCI as a staff clinician.  Dr. Korde joined the Breast Medical Oncology faculty at Seattle Cancer Care Alliance in July 2009. 

While at the NCI, Dr, Korde worked on a number of clinical and epidemiologic studies focusing on individuals at increased risk for cancer.  Her research focuses on applying epidemiologic methods and genetic knowledge to better understand and treat breast cancer and manage therapy-related toxicities.  Dr. Korde has an interest in breast cancer prevention, and is involved in several studies assessing lifestyle interventions and chemoprevention in women at increased risk of breast cancer.  She is also interested in assessing new modalities for the treatment of patients with early stage breast cancer.  She is a member of the Gynecologic Oncology Group where her work focuses on studies that relate to women at increased risk for breast and ovarian cancer based on a genetic or familial predisposition, and the Southwest Oncology Group, where her interest is in managing early stage breast cancer and assessing and managing therapy-related toxicities.